JSR Corp (4185):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】JSR Corp (4185) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C9901)・商品コード:DATA904C9901
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:37
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
JSR Corp (JSR), formerly Japan Synthetic Rubber Co Ltd is a chemical manufacturing company. It produces a synthetic rubbers, emulsions and plastics. The company, along with its subsidiaries, provides general-purpose synthetic rubbers, special purpose synthetic rubbers, thermoplastic elastomer (TPE) and various other related products. The company also develops semiconductor materials, optical materials, display materials, emulsion products and performance chemicals for information and communication industries through its proprietary polymer technologies. In addition, JSR manufactures synthetic resins including ABS resins, AES resins, AS resins, and ASA resins. Geographically, the company operates across the US, Singapore, Thailand, China, Germany, Belgium and Hong Kong among others. JSR is headquartered in Minato-Ku, Tokyo, Japan.

JSR Corp (4185) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JSR Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JSR Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JSR Corp, Medical Devices Deals, 2012 to YTD 2018 9
JSR Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
JSR Corp, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
KBI Biopharma Acquires Assets of Elion Labs 12
KBI Biopharma Acquires Manufacturing and Laboratory Assets of Opexa Therapeutics 13
KBI Biopharma To Acquire Biologics Operations Of Merck 14
Venture Financing 15
ReForm Biologics Raises Funds through Venture Financing 15
GlycoSeLect Raises USD0.5 Million in Seed Round of Financing 16
Aeglea BioTherapeutics Raises Additional USD1 Million in Series A Venture Financing 17
Partnerships 18
ReForm Biologics Enters into Agreement with KBI Biopharma 18
JSR Enters Into Co-Development Agreement With BIA Separations For Purification Technology 19
Licensing Agreements 20
JSR Enters into Licensing Agreement with Keio University 20
BiomX Enters into Licensing Agreement with JSR 21
Vedanta Biosciences Enters into Licensing Agreement with JSR Corp 22
Equity Offering 23
Coherus Biosciences Raises USD6.8 Million in Private Placement of Shares 23
Acquisition 24
JSR Acquires Crown Bioscience for USD399.7 Million 24
KBI Biopharma to Acquire Alliance Protein Labs 26
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 27
JSR to Acquire Stake in Medical & Biological Lab 28
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 29
JSR Acquires Minority Stake In Scivax Life Sciences 30
JSR Corp – Key Competitors 31
JSR Corp – Key Employees 32
JSR Corp – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
JSR Corp, Pharmaceuticals & Healthcare, Key Facts, 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JSR Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JSR Corp, Deals By Therapy Area, 2012 to YTD 2018 8
JSR Corp, Medical Devices Deals, 2012 to YTD 2018 9
JSR Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KBI Biopharma Acquires Assets of Elion Labs 12
KBI Biopharma Acquires Manufacturing and Laboratory Assets of Opexa Therapeutics 13
KBI Biopharma To Acquire Biologics Operations Of Merck 14
ReForm Biologics Raises Funds through Venture Financing 15
GlycoSeLect Raises USD0.5 Million in Seed Round of Financing 16
Aeglea BioTherapeutics Raises Additional USD1 Million in Series A Venture Financing 17
ReForm Biologics Enters into Agreement with KBI Biopharma 18
JSR Enters Into Co-Development Agreement With BIA Separations For Purification Technology 19
JSR Enters into Licensing Agreement with Keio University 20
BiomX Enters into Licensing Agreement with JSR 21
Vedanta Biosciences Enters into Licensing Agreement with JSR Corp 22
Coherus Biosciences Raises USD6.8 Million in Private Placement of Shares 23
JSR Acquires Crown Bioscience for USD399.7 Million 24
KBI Biopharma to Acquire Alliance Protein Labs 26
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 27
JSR to Acquire Stake in Medical & Biological Lab 28
JSR Acquires Minority Stake In Natrix Separations, Biotech Company 29
JSR Acquires Minority Stake In Scivax Life Sciences 30
JSR Corp, Key Competitors 31
JSR Corp, Key Employees 32
JSR Corp, Other Locations 34
JSR Corp, Subsidiaries 34
JSR Corp, Joint Venture 35

List of Figures
JSR Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
JSR Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
JSR Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
JSR Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
JSR Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
JSR Corp, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[JSR Corp (4185):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C9901)販売に関する免責事項を必ずご確認ください。
★調査レポート[JSR Corp (4185):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆